Molecular Templates hitches with Alnylam on RNAi delivery; PolyPid introduced new drug carriers;

> Molecular Templates a biopharmaceutical company developing what it calls a new class of small biologic therapies called Engineered Toxin Bodies has entered into a research collaboration with Alnylam Pharmaceuticals, which will  evaluate and develop Molecular Templates' technology for targeted delivery of RNAi therapies. No financial terms were disclosed. Release

> PolyPid has introduced a new family of drug carriers based on a melding of two drug delivery systems: polymers and lipid-based systems. The PolyPid carrier carrier can be tailored to small molecules, peptides, protein and nucleic acids-based drugs. Story

> Acrux receives boost from Europe for drug delivery technology for dogs. Item

> Independent clinical study validates Nanologica's new drug carrier material for oral use. Nanologica release